Chest Pain News and Research

RSS

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration accepted its supplemental Biologics License Application for Sprycel (dasatinib) in combination with chemotherapy for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.

30 Aug 2018

Around 8.4 million deaths occur each year from poor quality of care in low- and middle-income countries

Recent gains against the burden of illness, injury, and disability and commitment to universal health coverage are insufficient to close the enormous gaps that remain between what is achievable in human health and where global health stands today, says a new report from the National Academies of Sciences, Engineering, and Medicine.

29 Aug 2018

Drug used for chest pain does not decrease chance of first occurrence of ventricular arrhythmias

A clinical trial of more than 1,000 patients with implantable cardioverter defibrillators found that the drug ranolazine was safe but didn't significantly decrease the likelihood of the first occurrence of ventricular tachycardia, ventricular fibrillation or death in this high-risk population.

29 Aug 2018

Non-invasive test could help avoid unnecessary heart procedures

Unnecessary heart procedures can be avoided with a non-invasive test, according to late breaking research presented at ESC Congress 2018 and published in Journal of the American College of Cardiology.

28 Aug 2018

Study finds cause and history of spontaneous coronary artery dissection

The initial findings of a study on spontaneous coronary artery dissection, a major cause of heart attacks in women, are reported today in a late breaking science session at ESC Congress 2018.

28 Aug 2018

Patients with blood pressure must start treatment with two drugs as a single pill

A single pill with two drugs could transform blood pressure treatment, according to the 2018 European Society of Cardiology and European Society of Hypertension Guidelines on arterial hypertension published online today in European Heart Journal, and on the ESC website.

25 Aug 2018

New guidelines help decide if open heart surgery or stent is better after heart attack

New advice on the choice between open heart surgery and inserting a stent via a catheter after a heart attack is launched today.

25 Aug 2018

New guidance helps clear up confusion over how to diagnose heart attack

Confusion over how to diagnose a heart attack is set to be cleared up with new guidance launched today. The 2018 Fourth Universal Definition of Myocardial Infarction is published online in European Heart Journal, and on the ESC website.

25 Aug 2018

After-hours telemedicine can lead to fewer hospitalizations and more savings

When doctors could be reached via telemedicine to decide whether a patient in a skilled nursing facility (SNF) should be hospitalized, 29% of the patients evaluated avoided a hospital visit, saving $1.55 million over the course of a year, according to results reported in the current issue of The American Journal of Managed Care.

20 Aug 2018

FDA grants approval for first generic version of epinephrine auto-injector

The U.S. Food and Drug Administration today approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions, including those that are life-threatening (anaphylaxis), in adults and pediatric patients who weigh more than 33 pounds.

16 Aug 2018

Mono-antiplatelet therapy after aortic heart valve replacements may work as well as two drugs

Current treatment guidelines say patients who undergo minimally invasive aortic heart valve replacements should receive two antiplatelet drugs to reduce the risk of dangerous blood clots.

14 Aug 2018

New technology shows potential to streamline the analysis of proteins

New technology developed by a team of McGill University scientists shows potential to streamline the analysis of proteins, offering a quick, high volume and cost-effective tool to hospitals and research labs alike.

14 Aug 2018

Incidence of coronary artery compression in children may be more common than previously thought

The incidence of coronary artery compression in children fitted with epicardial pacemakers may be slightly more common than previously believed, say noted cardiologists.

13 Aug 2018

New high-sensitivity blood test quickly rules out heart attack in emergency room patients

A new test to assess a whether or not someone is having a heart attack upon arriving in the emergency room was safe and effective, ruling out heart attack in emergency room patients faster than a conventional method, according to new research in the American Heart Association's journal Circulation.

6 Aug 2018

Women having heart attacks experience longer wait time for cardiac intervention

A recent study shows women having heart attacks experience higher than 30% longer wait time from the onset of symptoms to hospital arrival than men and a higher than 20% longer time from hospital arrival to cardiac intervention compared to men.

1 Aug 2018

FDA approves first therapy for patients with rare tumors of the adrenal gland

The U.S. Food and Drug Administration today approved Azedra (iobenguane I 131) injection for intravenous use for the treatment of adults and adolescents age 12 and older with rare tumors of the adrenal gland (pheochromocytoma or paraganglioma) that cannot be surgically removed (unresectable), have spread beyond the original tumor site and require systemic anticancer therapy.

31 Jul 2018

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of Tafinlar® in combination with Mekinist® for the adjuvant treatment of adult patients with stage III melanoma with a BRAF V600 mutation, following complete resection.

27 Jul 2018

Therapy with L-Glutamine reduces pain in patients with sickle cell disease

UCSF Benioff Children's Hospital Oakland clinical researchers, in conjunction with other sickle cell centers and scientists at Emmaus Life Sciences, Inc., have demonstrated that therapy with L-Glutamine reduced the frequency of pain episodes in both pediatric and adult patients with sickle cell disease.

27 Jul 2018

New clinical trial examines use of adrenaline to treat cardiac arrests

A clinical trial of the use of adrenaline in cardiac arrests has found that its use results in less than 1% more people leaving hospital alive - but almost doubles the risk of severe brain damage for survivors of cardiac arrest.

19 Jul 2018

Study finds discharge against medical advice as predictor of readmissions in heart attack patients

In a new study led by Keele University researchers found discharge against medical advice as the strongest predictor of 30-day unplanned readmissions in heart attack patients.

18 Jul 2018

Chest Pain News and Research

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

Around 8.4 million deaths occur each year from poor quality of care in low- and middle-income countries

Drug used for chest pain does not decrease chance of first occurrence of ventricular arrhythmias

Non-invasive test could help avoid unnecessary heart procedures

Study finds cause and history of spontaneous coronary artery dissection

Patients with blood pressure must start treatment with two drugs as a single pill

New guidelines help decide if open heart surgery or stent is better after heart attack

New guidance helps clear up confusion over how to diagnose heart attack

After-hours telemedicine can lead to fewer hospitalizations and more savings

FDA grants approval for first generic version of epinephrine auto-injector

Mono-antiplatelet therapy after aortic heart valve replacements may work as well as two drugs

New technology shows potential to streamline the analysis of proteins

Incidence of coronary artery compression in children may be more common than previously thought

New high-sensitivity blood test quickly rules out heart attack in emergency room patients

Women having heart attacks experience longer wait time for cardiac intervention

FDA approves first therapy for patients with rare tumors of the adrenal gland

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Therapy with L-Glutamine reduces pain in patients with sickle cell disease

New clinical trial examines use of adrenaline to treat cardiac arrests

Study finds discharge against medical advice as predictor of readmissions in heart attack patients

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News